Intuitive Surgical Inc
ISRG: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| $744.00 | Phxq | Bxmzzkrys |
Intuitive Surgical Completes Three-to-One Stock Split
Business Strategy and Outlook
While the coronarvirus-marked 2020 was a challenging year for Intuitive Surgical, we anticipate it will be nothing but a small blimp on its radar. With patient volumes across the globe starting to show signs of recovery and hospitals budgets slowly unfreezing, focus once again turns to daVinci and its continuing adoption across all areas of soft tissue surgery. Our long-term positive view on the company's competitive positioning remains unchanged, even as new rivals are entering the previously monopolistic area of robot-assisted surgery.